Jahanzeb Malik.
Overlooked hepatotoxicity with Clopidogrel.
J Shifa Tameer-e-Millat Uni Jan ;3(2):132-3.

Clopidogrel is an adenosine diphosphate receptor blocker. It is widely used as a part of dual antiplatelet therapy (DAPT) in patients with ischemic heart disease (IHD), regardless of the acute coronary syndrome (ACS). Although a rarely reported entity, clopidogrel-induced liver injury is commonly seen in clinical practice. It is widely overlooked by clinicians and is thus a potential hazard to patients with IHD.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com